Leveraging Clinical Data to Enhance the Performance Evaluation of Ceftriaxone Population Pharmacokinetic Models in Children
Our external dataset comprised high ceftriaxone trough concentrations, indicating re-evaluation of current ceftriaxone dosing regimens to minimize the risk of overdosing and prevent toxicity. Future research should focus on the fine dosing balance for ceftriaxone, especially in patients with meningitis, by considering adequate exposure while preventing high trough concentrations. Model-informed precision dosing may enhance the use of the optimal individual dosage for critically ill children. However, our findings highlight the importance of externally evaluating ceftriaxone popPK models in the PICU population.
Authors
- Birgit C. P. Koch (ORCID: https://orcid.org/0000-0002-1202-3643)
- Tim Preijers (ORCID: https://orcid.org/0000-0001-6953-0358)
- Alan Abdulla (ORCID: https://orcid.org/0000-0002-2158-6376)
- Matthijs de Hoog (ORCID: https://orcid.org/0000-0002-1259-581X)
- Stef Schouwenburg (ORCID: https://orcid.org/0000-0003-1835-0749)
- Enno D. Wildschut (ORCID: https://orcid.org/0009-0005-5197-2656)
Institutions
- Erasmus MC (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Clinical Pharmacokinetics
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1007/s40262-025-01486-4
- Citations
- 2
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Erasmus Universitair Medisch Centrum Rotterdam